BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15796057)

  • 21. beta2-microglobulin-derived amyloidosis: an update.
    Floege J; Ketteler M
    Kidney Int Suppl; 2001 Feb; 78():S164-71. PubMed ID: 11169004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-2 microglobulin in ESRD: an in-depth review.
    Winchester JF; Salsberg JA; Levin NW
    Adv Ren Replace Ther; 2003 Oct; 10(4):279-309. PubMed ID: 14681859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta 2-microglobulin-related amyloidosis in patients receiving chronic hemodialysis.
    Gejyo F; Homma N; Maruyama H; Arakawa M
    Contrib Nephrol; 1988; 68():263-9. PubMed ID: 3069321
    [No Abstract]   [Full Text] [Related]  

  • 24. Beta 2-microglobulin modified with the AGE products of the Maillard reaction in dialysis-related amyloidosis.
    Miyata T; Wada Y; Maeda K
    Contrib Nephrol; 1995; 112():52-64. PubMed ID: 7554993
    [No Abstract]   [Full Text] [Related]  

  • 25. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of dialysis amyloid after renal transplantation. A case report.
    Sethi D; Brown EA; Cary NR; Woodrow DF; Gower PE
    Am J Nephrol; 1989; 9(2):173-4. PubMed ID: 2662775
    [No Abstract]   [Full Text] [Related]  

  • 27. Pathogenesis of beta2-microglobulin amyloidosis.
    Ohashi K
    Pathol Int; 2001 Jan; 51(1):1-10. PubMed ID: 11148456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
    Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
    Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent progress in understanding dialysis-related amyloidosis.
    Yamamoto S; Kazama JJ; Narita I; Naiki H; Gejyo F
    Bone; 2009 Jul; 45 Suppl 1():S39-42. PubMed ID: 19303954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.
    Miyata T; Maeda K
    Nephrol Dial Transplant; 1996; 11 Suppl 2():140-3. PubMed ID: 8804015
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term management of dialysis patients. II. Beta 2-microglobulin associated amyloidosis and acquired cystic kidney disease].
    Floege J; Segerer S; Schäffer J; Koch KM
    Internist (Berl); 1999 Jan; 40(1):64-9. PubMed ID: 10086302
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products.
    Niwa T
    Nephron; 1997; 76(4):373-91. PubMed ID: 9274834
    [No Abstract]   [Full Text] [Related]  

  • 33. B2-microglobulin and associated amyloidosis presenting as bilateral popliteal tumors.
    Reese W; Hopkovitz A; Lifschitz MD
    Am J Kidney Dis; 1988 Oct; 12(4):323-5. PubMed ID: 3052048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta2-microglobulin and amyloidosis.
    Drüeke TB
    Nephrol Dial Transplant; 2000; 15 Suppl 1():17-24. PubMed ID: 10737162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dialysis-related amyloidosis.
    Koch KM
    Kidney Int; 1992 May; 41(5):1416-29. PubMed ID: 1614057
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta 2-microglobulin-related amyloidosis: where do we stand?
    Gejyo F; Arakawa M
    Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
    Higuchi N; Maruyama H
    Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum.
    Niwa T; Katsuzaki T; Momoi T; Miyazaki T; Ogawa H; Saito A; Miyazaki S; Maeda K; Tatemichi N; Takei Y
    Kidney Int; 1996 Mar; 49(3):861-7. PubMed ID: 8648931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is beta 2-microglobulin a mediator of bone disease?
    Sprague SM; Popovtzer MM
    Kidney Int; 1995 Jan; 47(1):1-6. PubMed ID: 7731134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.